H. pylori infection of the stomach. Other and unspecified infectious diseases
Conditions
Interventions
Intervention group 2: intervention group 1 drugs plus two capsules containing 500mg of powdered Pistacia Atlantica kurdica bd for 14 days.
Intervention 1: Control group: Two placebo capsules, 500 mg (bd) for 14 days. Intervention 2: Intervention group 1: 500 mg of Amoxicillin bd, Clarithromycin 500 mg bd and Omeprazole 20 mg bd, obtained
Placebo
Treatment - Drugs
Control group: Two placebo capsules, 500 mg (bd) for 14 days
Intervention group 1: 500 mg of Amoxicillin bd, Clarithromycin 500 mg bd and Omeprazole 20 mg bd, obtained from Pharmaceutical Sobhan for 14 days
Intervention group 3: two capsules containing two 500mg of powdered Pistacia Atlantica kurdica obtained from Department of Pharmacology, Shiraz University of Medical Sciences bd for 14 days
Sponsors
Vice chancellor for Research Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria Gastrointestinal clinic patients 20 to 40 years old; UBT positive symptoms of indigestion; avoiding the use of antibiotics Exclusion criteria Pregnancy and lactation; the development of pharmaceutical agents stopped the study; travel or unwillingness to continue treatment; lack of medication; taking the wrong medication
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function changes. Timepoint: 2 days before and 30 days after the intervention. Method of measurement: According to the DOB. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache - abdominal pain - diarrhea - nausea. Timepoint: During the intervention. Method of measurement: Qualitative. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamidollah Afrasiabian,MD
Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Scien
Outcome results
None listed